While more of the puzzle is being pieced together from a scientific perspective, it will still take years to conduct and complete the rigorous clinical research necessary to put these tests into everyday practice, one of the challenges to developing a blood test to detect early-stage cancers is that the bloodstream only has minute levels of tumor DNA.